Traboulsee A, Arnold DL, Klawiter EC, et al. Association of brain volume loss and NEDA outcomes in patients with relapsing multiple sclerosis in the OPERA I and OPERA II studies. ECTRIMS 2017, P774.
Vergoeding selumetinib (Koselugo) voor kinderen met neurofibromatose type 1
mei 2024